Nuvalent (NUVL) Cash & Equivalents (2020 - 2026)

Nuvalent has reported Cash & Equivalents for 7 years, with the latest figure at $159.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 32.19% year-over-year to $159.7 million; the trailing twelve-month figure through Mar 2026 stood at $159.7 million (up 32.19% YoY), and the FY2025 full-year result was $261.7 million, up 79.66% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $159.7 million, down from $261.7 million in the prior quarter.
• The five-year high for Cash & Equivalents was $369.2 million in Q3 2024, with the low at $67.3 million in Q1 2022.
• Historically, Cash & Equivalents has averaged $148.4 million across 5 years, with a median of $115.8 million in 2025.
• Annual changes were most pronounced in 2022 — Cash & Equivalents plunged 68.96% — and 2024, when it surged 317.54%.
• Nuvalent's Cash & Equivalents stood at $241.8 million in 2022, then surged by 38.7% to $335.4 million in 2023, then plunged by 56.56% to $145.7 million in 2024, then surged by 79.66% to $261.7 million in 2025, then tumbled by 38.97% to $159.7 million in 2026.
• The last three Cash & Equivalents figures came in at $159.7 million (Q1 2026), $261.7 million (Q4 2025), and $115.8 million (Q3 2025), per Business Quant data.